关注
Xuekun Wu
Xuekun Wu
在 stanford.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Angiogenesis after acute myocardial infarction
X Wu, MR Reboll, M Korf-Klingebiel, KC Wollert
Cardiovascular Research 117 (5), 1257-1273, 2021
2072021
Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial
X Huo, HM Krumholz, X Bai, ES Spatz, Q Ding, P Horak, W Zhao, Q Gong, ...
Circulation: Cardiovascular Quality and Outcomes 12 (9), e005805, 2019
612019
Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial
X Zheng, ES Spatz, X Bai, X Huo, Q Ding, P Horak, X Wu, W Guan, ...
Circulation: Cardiovascular Quality and Outcomes 12 (4), e005616, 2019
522019
Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase
MR Reboll, S Klede, MH Taft, CL Cai, LJ Field, KJ Lavine, AL Koenig, ...
Science 376 (6599), 1343-1347, 2022
442022
Heparan sulfate–editing extracellular sulfatases enhance VEGF bioavailability for ischemic heart repair
M Korf-Klingebiel, MR Reboll, K Grote, H Schleiner, Y Wang, X Wu, ...
Circulation research 125 (9), 787-801, 2019
392019
Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression …
M Korf-Klingebiel, MR Reboll, F Polten, N Weber, F Jäckle, X Wu, ...
Circulation 144 (15), 1227-1240, 2021
312021
Traditional Chinese medicine for acute myocardial infarction in western medicine hospitals in China
ES Spatz, Y Wang, AL Beckman, X Wu, Y Lu, X Du, J Li, X Xu, ...
Circulation: Cardiovascular Quality and Outcomes 11 (3), e004190, 2018
262018
Heparan sulfate-editing extracellular sulfatases enhance vascular endothelial growth factor bioavailability for ischemic heart repair
M Korf-Klingebiel, MR Reboll, K Grote, H Schleiner, Y Wang, X Wu, ...
Circulation research 125 (9), 2019
52019
Effect of Cardiovascular Health and Text Messaging (CHAT) on Risk Factor Management in Patients with Coronary Heart Disease: A Randomized Clinical Trial
X Zheng, ES Spatz, X Bai, X Huo, Q Ding, P Horak, X Wu, W Guan, ...
Circulation: Cardiovascular Quality and Outcomes 12 (Suppl_1), A293-A293, 2019
32019
Lnc-ing epicardium-derived cells to cardiac remodelling: lncRNA-TARID as a novel antifibrotic option
X Wu, F Vacante, JC Wu
European Heart Journal 44 (19), 1761-1763, 2023
12023
Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair
X Wu, L Zheng, MR Reboll, LF Hyde, E Mass, HW Niessen, M Kosanke, ...
Nature Cardiovascular Research, 1-17, 2024
2024
Myeloid-derived Growth Factor Ameliorates Cardiac Fibrosis Via Shedding TGFBR1 in Fibroblasts
X Wu
Medizinische Hochschule Hannover, 2022
2022
Application and Affecting Factor Analysis of Clopidogrel Loading Therapy in STEMI Patients With Percutaneous Coronary Intervention in China in 2006 and 2011
X WU, L Zhang, X Zheng, M SU, J Liu, H Zhang, X Bai, X LI, L Jiang
Chinese Circulation Journal, 432-436, 2016
2016
系统目前无法执行此操作,请稍后再试。
文章 1–13